Tumor Heterogeneity, Plasticity and Therapy (3rd edition)

Add to calendar

It is with great pleasure that we announce the third edition of the VIB conference ‘Tumor heterogeneity, plasticity and therapy’. Growing evidence highlights the bi-directional interactions between tumor cells and their microenvironment as key drivers of tumor evolution and therapy resistance.

Within a tumor, cancer cells exhibit significant variability, which poses a major challenge for therapy, as treatments often target only a subset of tumor cells. Furthermore, cancer cell plasticity enables rapid adaption to therapeutics and the development of tolerance and resistance, presenting additional challenges for both targeted and immunotherapies.

21 distinguished invited speakers will share their latest research and insights in the following topics:

Plasticity and initiation
Progression and metastasis
Therapy resistance (fundamental)
Therapy resistance (translational/clinical)

During the event, we anticipate vibrant discussions and collaborations that will not only highlight recent breakthroughs but also pave the way for transformative advancements in the fight against cancer.

Speakers

Julio Aguirre-Ghiso - Albert Einstein College of Medicine, US
Kelly Bolton - Washington University, US
Anwesha Dey - Genentech, US
Johanna Joyce - University of Lausanne, Ludwig Institute for Cancer Research, CH
Ben Simons - Cambridge Stem Cell Institute, UK
and many more.. visit our website for a full overview of all speakers

Discover the program

Deadlines